CCAAT/enhancer-binding proteins (C/EBPs) are a six-member family of basic-region leucine-zipper transcription factors that run terminal differentiation: C/EBPα and β drive adipogenesis alongside PPARγ, C/EBPα commits granulocyte formation in the marrow (acute myeloid leukemia's biallelic mutations), and the liver's acute-phase and metabolic genes answer to C/EBPβ/δ. Their design is modular — N-terminal transactivation, C-terminal bZIP dimerisation — and their biology is timing: they are the "commit and stop dividing" factors, which is why their loss releases cells from differentiation.